T1	Participants 35 59	malaria chemoprophylaxis
T2	Participants 170 332	malaria chemoprophylaxis regimens (atovaquone-proguanil, chloroquine-proguanil, doxycycline, or mefloquine) in a group of nonimmune tourists to sub-Saharan Africa
T3	Participants 427 478	travel clinics in Switzerland, Germany, and Israel,
T4	Participants 930 936	Africa
T5	Participants 1455 1500	below median age 34 y vs median age and above
T6	Participants 1658 1694	Younger participants, aged <34 years
T7	Participants 1845 1887	standard malaria chemoprophylaxis regimens
T8	Participants 1903 1908	women
T9	Participants 1965 1968	men
T10	Participants 1978 2018	younger persons aged less than 34 years,
T11	Participants 2101 2119	older counterparts
